Navigation Links
Neurologix Announces First Quarter 2011 Financial Results
Date:5/13/2011

ization of $394 and $364 at March  31, 2011 and December 31, 2010, respectively

1,110

1,065Other assets

5

5Total assets

$7,067

$9,677LIABILITIES AND STOCKHOLDERS' DEFICITCurrent liabilities:Accounts payable and accrued expenses

$2,321

$2,302Notes payable, net of discount

5,387

4,695Total current liabilities

7,708

6,997Derivative financial instruments, at estimated fair value - warrants

5,497

6,840Total liabilities

13,205

13,837Commitments and contingenciesStockholders' deficit: Preferred stock; 5,000,000 shares authorizedSeries A – Convertible, $0.10 par value; 650 shares designated, 645 shares issued and outstanding at March  31, 2011 and December 31, 2010, with an aggregate liquidation preference of $1

-

-Series C – Convertible, $0.10 par value; 700,000 shares designated, 278,849 shares issued and outstanding  at March  31, 2011 and December 31, 2010 with an aggregate liquidation preference of $8,086 and $8,369 at March  31, 2011 and December 31, 2010, respectively

28

28Series D – Convertible, $0.10 par value; 792,100 shares designated, 734,898 shares issued and outstanding at March  31, 2011 and December 31, 2010, with an aggregate liquidation preference of $32,017 and $32,547 at March  31, 2011 and December 31, 2010, respectively

73

73 Common Stock:$0.001 par value; 100,000,000 shares authorized, 27,918,148 shares issued and outstanding at March 31, 2011 and December 31, 2010

28

28 Additional paid-in capital

57,578

57,474Deficit accumulated during the development stage

(63,845)

(61,763)Total stockholders' deficit

(6,138)

(4,160)Total liabilities and stockholders' deficit

$7,067

$9,677NEUROLOGIX, INC.(A Development Stage Company)STATEMENTS OF OPERATIONS(UNAUDITED)(Amo
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
3. Neurologix Reports Third Quarter 2010 Financial Results
4. Neurologix Completes Additional $7 Million Financing
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Conn. , May 17, 2013 /PRNewswire-iReach/ -- ... and recombinant proteins, is placing renewed emphasis on ... the rise as a number of factors are ... for pharmaceutical makers and their delivery device partners ... previously refractory conditions, the growing trend toward self-administration ...
(Date:5/17/2013)... May 17, 2013  Boehringer Ingelheim will contribute ... at the American Thoracic Society International Conference (ATS ... May 17 – 22. Data will ... the treatment of chronic obstructive pulmonary disease (COPD) ... as investigational compounds for asthma, idiopathic pulmonary fibrosis ...
(Date:5/17/2013)... 2013  Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... Mylan Inc. (Nasdaq: MYL ) today announced plans ... injectable pharmaceutical company for $550 million in cash. ... into the North American injectables market but also a platform ... accretive to Mylan,s earnings in year one, without accounting for ...
... The American Veterinary Medical Association (AVMA) today cautioned against federal bans ... , , ... of Representative,s Committee on Energy and Commerce Subcommittee on Health, the AVMA,s ... can have far-reaching impacts on both animal and human health. Dr. Hoang ...
Cached Medicine Technology:Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business 2Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business 3Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business 4Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business 5AVMA Testifies in Support of Judicious Use of Antimicrobials in Food Animals 2
(Date:5/18/2013)... Serena Gordon HealthDay Reporter , , FRIDAY, May 17 ... students sometimes binge drink, but new research shows that college ... on a weekly basis than are college men. ... alcohol that,s considered safe on a weekly basis is much ... for women versus 14 for men. But, there,s good reason ...
(Date:5/18/2013)... New York, New York (PRWEB) May 18, 2013 ... continue to mount in courts throughout the country, Bernstein ... that metal-on-metal hip replacement patients often suffer tissue damage ... During the study, which according to Science Daily will ... 69 metal-on-metal hip replacement recipients underwent MRI screens of ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 6Webs.com ... The simple to read reviews and comprehensive comparisons make ... impartial home security reviews. 6Webs.com just recently finished conducting ... system providers. , Tim Smythe from 6Webs.com reports, "There ... systems due to their ease of use, expandability and ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 Rio ... has recently completed a stylish renovation that features tranquil, ... specialties. , From the ground up, this Morro ... with fresh flooring, soothing colors and comfortable spa beds. ... installed, including an Apilus epilator machine. The shampoo ...
(Date:5/18/2013)... Scott Tischler of Tischler Brothers Fitness helped ... keys to losing weight played a huge part in Troy ... Tischler, Troy was able to lose a pound a day. ... should be approached with caution and any activity should be ... keys to weight loss that Scott Tischler advocates. With these ...
Breaking Medicine News(10 mins):Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2
... Hispanic health advocates committed to achieving meaningful health care reform ... U.S. House of Representatives showed they have heard the voice ... America Act. Now the Senate must deliver, without delay, on ... L. Delgado, President and CEO of the National Alliance for ...
... and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson ... bill: , "We are disappointed, but not surprised by today,s ... as well as nearly half of the members of the ... "While well intentioned, the bill -- as passed -- would ...
... The following was released today by Randall Terry, Director, Operation Rescue ... the country have been fighting to keep child-killing by abortion out ... "This is a great first step to victory -- a touchdown ... fighting ahead of us. Our rejoicing must be tempered by reality. ...
... Health Care Vote Shows Who Sides With Working Families vs. ... the heels of an historic late night vote in the ... bill, the Pennsylvania AFL-CIO released its scoring of how our ... Care for America Act. , The legislation, which passed ...
... of Dimes hosted the Fourth Annual Celebration of Babies ... birth of their children and who are role models ... of babies. As part of the March of ... guests were urged to join the fight for preemies! ...
... Nancy Pelosi spoke on the House floor today in support of ... House will vote on the legislation later tonight. Below are ... know, is an historic moment for our nation and for American ... political philosophy -- as far back as Teddy Roosevelt -- have ...
Cached Medicine News:Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: